Clinical, biochemical profile and atherosclerotic cardiovascular risk score (ASCVD) in patients with high HDL cholesterol

被引:0
作者
Mallya, Raksha Udupi [1 ]
Vidyasagar, Sudha [1 ]
Varashree, B. S. [2 ]
Sukumar, Cynthia Amrutha [1 ]
机构
[1] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Gen Med, Manipal 576104, Karnataka, India
[2] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India
关键词
ASCVD; CETP; HDL cholesterol; Lipidology; METs; CORONARY-HEART-DISEASE; ALCOHOL-CONSUMPTION; ATHEROGENIC DYSLIPIDEMIA; HYPERTENSION; POPULATION; JAPANESE; GENE;
D O I
10.1007/s11845-025-03878-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIt was observed that many people in the western coastal belt were found to have a high HDL cholesterol, the cause of which was not known. This study was done to learn about the factors contributing to the high HDL cholesterol in these patients and its effect on ASCVD risk.MethodsIn this prospective, case control study, 150 patients were recruited, of which 63 were cases (patients with high HDL cholesterol), and 87 were controls (patients with normal HDL cholesterol). Details regarding their diet, sea-food consumption, habits, comorbidities, daily activity (using GPAQ questionnaire), and blood reports were collected. ASCVD risk score was calculated using an online ASCVD risk estimator. Blood samples of 96 patients (cases 40, controls 56) was tested for cholesterol esterase transfer protein (CETP) levels using ELISA, and the results were compared.ResultsPatients with high HDL cholesterol were found to be physically more active and had median metabolic equivalent (METs) of 4680 (1200, 8580) compared with controls with median METs of 1680 (720, 5580), P-0.013. Cases had a lower mean BMI 23.09(SD-3.69), than in patients with normal HDL cholesterol with a mean of 24.41(SD-4.01), P-0.04. Cases also had a lower triglyceride level (91(69,118) in cases vs 121 (80,151) in controls, P-0.002. Alcohol and sea food consumption had no role on HDL levels in this study. The median CETP level was lower in patients with high HDL levels, 0.336(0.08, 0.336) versus 1.435(0.061, 2.893) in the control group although not statistically significant. Patients with high HDL cholesterol were found to have a significantly lower median 10-year ASCVD risk score 3.05 (0.6, 8.95), compared with patients with normal HDL 6.45 (2.7,14.2).ConclusionPatients with high HDL cholesterol were found to be physically more active, had a lower BMI, a lower triglyceride level, and a lower ASCVD risk compared with controls. They also had a lower CETP level. Further research will be required to determine the normal CETP level in Indian population, their genetic makeup, and whether it has a role in cardiovascular protection.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 50 条
  • [31] Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol
    Luo, Yonghong
    Peng, Daoquan
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 28
  • [32] High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the "U"-Shaped Curve
    Razavi, Alexander C.
    Mehta, Anurag
    Jain, Vardhmaan
    Patel, Parth
    Liu, Chang
    Patel, Nidhi
    Eisenberg, Scott
    Vaccarino, Viola
    Isiadinso, Ijeoma
    Sperling, Laurence S.
    Quyyumi, Arshed A.
    [J]. CURRENT CARDIOLOGY REPORTS, 2023, 25 (12) : 1725 - 1733
  • [33] Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
    Langlois, Michel R.
    Sniderman, Allan D.
    [J]. CURRENT CARDIOLOGY REPORTS, 2020, 22 (08)
  • [34] Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan
    Mitani, Hironobu
    Suzuki, Kota
    Ako, Junya
    Iekushi, Kazuma
    Majewska, Renata
    Touzeni, Salsabil
    Yamashita, Shizuya
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (11) : 1622 - 1634
  • [35] Should we target HDL cholesterol level in lowering cardiovascular risk?
    Toth, Peter P.
    [J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (10): : 667 - 671
  • [36] Improving the prediction of cardiovascular risk: Interaction between LDL and HDL cholesterol
    Grover, SA
    Dorais, M
    Coupal, L
    [J]. EPIDEMIOLOGY, 2003, 14 (03) : 315 - 320
  • [37] The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis
    Ganjali, Shiva
    Watts, Gerald F.
    Banach, Maciej
    Reiner, Zeljko
    Nachtigal, Petr
    Sahebkar, Amirhossein
    [J]. CURRENT MEDICINAL CHEMISTRY, 2021, 28 (29) : 6066 - 6081
  • [38] HDL-cholesterol: an important factor to evaluate a cardiovascular risk in practice
    Guinchard-Foulon, E
    Rodriguez-Lafrasse, C
    Rousson, R
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2003, 61 (05) : 549 - 556
  • [39] Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
    Golabi, Pegah
    Fukui, Natsu
    Paik, James
    Sayiner, Mehmet
    Mishra, Alita
    Younossi, Zobair M.
    [J]. HEPATOLOGY COMMUNICATIONS, 2019, 3 (08) : 1050 - 1060
  • [40] Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels
    Corsetti, James P.
    Ryan, Dan
    Moss, Arthur J.
    McCarthy, Jeanette J.
    Goldenberg, Ilan
    Zareba, Wojciech
    Sparks, Charles E.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) : 1170 - 1178